School personnel information




gynecologic cancer, peritoneal metastasis

Mail Address

Mail Address

Organization 【 display / non-display

  • 2011.04.01 - , Graduate School of Medicine, Assistant Professor


Academic Papers 【 display / non-display

  • Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers., Shimizu A, Sawada K, Shiomi M, Kawano M, Matsumoto Y, Takiuchi T, Kodama M, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Tomimatsu T, Kimura T, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,147(2) 252-257, 2019.11, Papers

  • Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells, Yoshimura, A. Sawada, K. Nakamura, K. Kinose, Y. Nakatsuka, E. Kobayashi, M. Miyamoto, M. Ishida, K. Matsumoto, Y. Kodama, M. Hashimoto, K. Mabuchi, S. Kimura, T., BMC Cancer,18:1065, 2018.11, Papers

  • Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer., Yokoi E, Mabuchi S, Shimura K, Komura N, Kozasa K, Kuroda H, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T., Invest New Drugs,Epub ahead of print, 2018.10, Papers

  • Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types, Kobayashi, M. Sawada, K. Nakamura, K. Yoshimura, A. Miyamoto, M. Shimizu, A. Ishida, K. Nakatsuka, E. Kodama, M. Hashimoto, K. Mabuchi, S. Kimura, T., J Ovarian Res,11:81, 2018.09, Papers

  • Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer, Kuroda, H. Mabuchi, S. Yokoi, E. Komura, N. Kozasa, K. Matsumoto, Y. Kawano, M. Takahashi, R. Sasano, T. Shimura, K. Kodama, M. Hashimoto, K. Sawada, K. Morii, E. Kimura, T., Oncotarget, 9:36317-36330, 2018.09, Papers

display all >>